Skip to main content
MEHA
NASDAQ Life Sciences

Functional Brands Reports Q4 & FY2025 Profitability, $2.5M Cash Surge, Mitigating Going Concern Risk

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Positive
Importance info
9
Price
$0.147
Mkt Cap
$2.393M
52W Low
$0.13
52W High
$8
52W Position info
13% above low
Off High info
98% below high
Rel. Volume
Market data snapshot near publication time

MEHA is trading near its 52-week low of $0.13 (13% above the low).

Summary

Functional Brands Inc. announced a significant financial turnaround for Q4 and full-year 2025, reporting net income and a substantial increase in cash, which directly addresses the going concern warning issued in its recent 10-K.


Key Events · Earnings and Guidance · MEHA

  • Achieved Profitability

    Reported net income of $0.9 million for Q4 2025 and $0.8 million for full-year 2025, a significant turnaround from prior year losses.

  • Substantial Cash Increase

    Cash balance surged from $0.2 million to $2.7 million by year-end 2025, providing critical liquidity.

  • Positive Stockholders' Equity

    Shifted from a stockholders' deficit to positive equity of $1.5 million, indicating improved financial health.

  • Mitigates Going Concern Warning

    These strong financial results directly address the "going concern" warning and delisting risks highlighted in the recent 10-K filing.


Analysis · MEHA · Life Sciences

This 8-K provides crucial financial results that offer a stark contrast to the dire outlook presented in the company's 10-K just three days prior. The shift from a net loss to a net income for both the fourth quarter and the full fiscal year 2025, coupled with a substantial increase in cash from $0.2 million to $2.7 million, significantly improves the company's liquidity and financial stability. This positive performance, driven in part by an $8 million preferred stock issuance, directly mitigates the "going concern" warning and Nasdaq delisting risks previously disclosed. Investors should view these results as a strong signal of improved operational health and a potential turning point for the company.

At the time of this filing, MEHA was trading at $0.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.13 to $8.00. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEHA - Latest Insights

MEHA
Jul 02, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0043
Real-time Price: $0.0043 info
Change: $0 (0%) info
Market Cap: $181.488K info
MEHA
Jun 30, 2026, 6:46 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0052
Real-time Price: $0.0043 info
Change: -$0.0009 (-17%) info
Market Cap: $181.488K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0416
Real-time Price: $0.0043 info
Change: -$0.0373 (-90%) info
Market Cap: $181.488K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
10
Price at Filing: $0.038
Real-time Price: $0.0043 info
Change: -$0.0337 (-89%) info
Market Cap: $181.488K info
MEHA
Jun 05, 2026, 2:29 PM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.0722
Real-time Price: $0.0043 info
Change: -$0.0679 (-94%) info
Market Cap: $181.488K info